SEP 09, 2019 9:33 AM PDT

Cannabis Buds for Mid-Level Pain Relief

WRITTEN BY: Julia Travers

A study called, "The Effectiveness of Self-Directed Medical Cannabis Treatment for Pain," published in the journal Complementary Therapies in Medicine found cannabis buds or flowers are reported by users to be an effective mid-level analgesic medication for pain. The results were gleaned from the data of an app called the Releaf App, an incentive-free program that has been in use since 2016.

 

Releaf App allows cannabis users to track how the many available cannabis-based products affect their pain in real-time. According to Science Daily, the average user experienced a three-point drop in pain on a 0-10 point scale right after cannabis consumption.

Chronic pain burdens many adults (more than 20 percent in the U.S.) and places a major financial strain on the country. Given the ongoing opioid epidemic, use of cannabis is viewed by some medical professionals as a welcome alternative.

"Cannabis offers the average patient an effective alternative to using opioids for general use in the treatment of pain with very minimal negative side effects for most people,” Jacob Miguel Vigil, one of the lead investigators of the study, said. The authors do note that addiction is possible along with short-term cognitive and behavioral impairments, and that cannabis comes in many forms and is not equally effective for everyone.

"Perhaps the most surprising result is just how widespread relief was with symptom relief reported in about 95 percent of cannabis administration sessions and across a wide variety of different types of pain," lead author of the study, Xiaoxue Li, said.

The authors also report that CBD showed little association with short-term pain relief. They point out that the Releaf App can be very helpful to scientists at this time when cannabis is still scheduled as a Schedule I substance, which makes it harder to research. Co-author Sarah Stith said rescheduling cannabis “just from Schedule I to Schedule II,” could improve the ability to conduct research “and only would require that the DEA recognizes that accepted medical uses for cannabis exist, as clearly evidenced by our results and the flourishing medical cannabis programs in the majority of U.S. states.”

Article source: Science Daily

 
About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
JAN 07, 2021
Health & Medicine
How Cannabis Might Help Fibromyalgia
JAN 07, 2021
How Cannabis Might Help Fibromyalgia
Fibromyalgia affects as many as 4 million adults in America  (2 percent of the adult population) and is a debilitat ...
MAR 17, 2021
Health & Medicine
CBD Inhibits Brain Changes that Initiate  Alzheimer's: Animal Study
MAR 17, 2021
CBD Inhibits Brain Changes that Initiate Alzheimer's: Animal Study
Cannabidiol, or CBD — the main non-psychoactive ingredient in cannabis — may inhibit some triggers for Alzhe ...
APR 10, 2021
Cannabis Sciences
Cannabis Users Exercise More than Nonusers
APR 10, 2021
Cannabis Users Exercise More than Nonusers
The rate of cannabis use among American adults tripled between 2003 and 2018 from 4.1% to 15.9%. During this time, some ...
APR 15, 2021
Health & Medicine
Concerns Over Delta-8?
APR 15, 2021
Concerns Over Delta-8?
Delta-8-THC is a hemp byproduct that’s being exploited by an apparent loophole in federal law that allows its unfe ...
MAY 04, 2021
Health & Medicine
Micro-dosing Inhaler Breakthrough for Medical Cannabis
MAY 04, 2021
Micro-dosing Inhaler Breakthrough for Medical Cannabis
In a leap that will eliminate the risks of vaping or smoking, Canada has just approved an Israeli-made inhaler that is a ...
JUN 02, 2021
Cannabis Sciences
Can CBD Help Manage Symptoms of Diabetes?
JUN 02, 2021
Can CBD Help Manage Symptoms of Diabetes?
As cannabidiol (CBD) products become increasingly mainstream, more people are using them to manage symptoms for chronic ...
Loading Comments...